In HCC specifically, TREM2’s modulation of macrophage activity within the liver can either promote a pro-tumorigenic environment conducive to cancer progression or enhance immune checkpoint blockade therapy, depending on its expression levels and the context of other immune modulators within the TME (34). This evidence concerns the gene TREM2 and cancer.